Oxford Index Search Results

You are looking at 1-20 of 99 items for:

decision-making x Neurology x Medical Oncology x clear all

Show only full text

Refine by type

Refine by product

 

SHARED DECISION MAKING, THE BRIDGE BETWEEN PATERNALISM AND AUTONOMY.

Julian Cahill, Georgios Zilidis and Paul Grundy.

in Neuro-Oncology

October 2018; p ublished online October 2018 .

Journal Article. Subjects: Medical Oncology; Neurology. 0 words.

Abstract

INTRODUCTION

Shared Decision Making (SDM) has been shown to be an effective tool in allowing patients to...

Go to »  full text

HGG-09. DECISION MAKING IN THE FACE OF INCURABLE HIGH GRADE GLIOMAS: A QUALITATIVE ANALYSIS

Ashley F Lanzel, Katharine E Brock, Abby R Rosenberg, Justin N Baker, Amy E Caruso Brown, Ann Mertens, Rebecca Pentz and Karen Wasilewski-Masker.

in Neuro-Oncology

June 2018; p ublished online June 2018 .

Journal Article. Subjects: Medical Oncology; Neurology. 0 words.

Abstract

BACKGROUND

For children/young adults with incurable high grade gliomas (HGGs), oncologists strive to align...

Go to »  full text

P01.127 The impact of first MR in clinical decision making of patients with high grade glioma treated with radio-chemotherapy

M Cantarella, F Pasqualetti, A Molinari, A Gonnelli, M Cosottini and F Paiar.

in Neuro-Oncology

September 2018; p ublished online September 2018 .

Journal Article. Subjects: Medical Oncology; Neurology. 0 words.

Abstract

Background

Standard up-front therapy of high grade glioma (HGG) is focused on the so called Stupp...

Go to »  full text

P09.10 Clinical fMRI in low grade glioma patients: impact on surgical decision making and patient outcomes

S. E. Kosteniuk, J. C. Lau and J. F. Megyesi.

in Neuro-Oncology

October 2016; p ublished online September 2016 .

Journal Article. Subjects: Medical Oncology; Neurology. 0 words.

Background:

This study aims to evaluate the impact of preoperative functional magnetic resonance imaging (fMRI) on low grade glioma (LGG) patients’ outcomes...

NIMG-38. QUALITY OF SURGICAL DECISION MAKING FOR PATIENTS WITH A GLIOBLASTOMA IS SIMILAR BETWEEN NEURO-ONCOLOGICAL CARE TEAMS FROM THE UNITED STATES OF AMERICA AND THE NETHERLANDS

Domenique M J Müller, Pierre Robe, Seunggu J Han, Frederik Barkhof, William Peter Vandertop, Mitchel S Berger and Philip C de Witt Hamer.

in Neuro-Oncology

November 2017; p ublished online November 2017 .

Journal Article. Subjects: Medical Oncology; Neurology. 0 words.

Abstract

INTRODUCTION

The extent of resection is important to improve survival in patients with a glioblastoma. The...

Go to »  full text

P05.82 Clinical decision making. The route from an ontology to a prediction model for stereotactic radiotherapy: PRE.M.I.S.E. (PREdiction Models in Stereotactic External Radiotherapy)

F Bianciardi, S Chiesa, B Tolu, S Longo, G Minniti, B Nardiello, F Cellini, F Rea, P Gentile and V Valentini.

in Neuro-Oncology

September 2018; p ublished online September 2018 .

Journal Article. Subjects: Medical Oncology; Neurology. 0 words.

Abstract

Background

It becomes more and more clear that people with the same cancer can have different forms of the...

Go to »  full text

GERM-22. DECISION-MAKING MANAGEMENT GUIDELINE FOR CHILDREN AND YOUNG PEOPLE UP TO 19 YEARS (CYP) PRESENTING WITH IDIOPATHIC PITUITARY STALK THICKENING (iTPS) AND/OR IDIOPATHIC CENTRAL DIABETES INSIPIDUS (iCDI)

Manuela Cerbone, Johannes Visser, Chloe Bulwer, Ashraf Ederies, Kirtana Vallabhaneni, Stephen Ball, Ian Kamaly, Ashley Grossman, Helena Gleeson, Marta Korbonits, Vasanta Nanduri, Vaya Tziaferi, Tom Jacques and Helen A Spoudeas.

in Neuro-Oncology

June 2018; p ublished online June 2018 .

Journal Article. Subjects: Medical Oncology; Neurology. 0 words.

Abstract

AIM: To develop a high-quality national guideline for the assessment and management of CYP presenting with iTPS and/or iCDI before their 19th...

Go to »  full text

PATH-52. UTILIZING NEXT GENERATION SEQUENCING REPORTS IN CLINICAL DECISION MAKING: REPORT FROM THE NATIONAL INSTITUTES OF HEALTH (NIH) NEURO-ONCOLOGY BRANCH (NOB) NATURAL HISTORY STUDY (NHS) PRIMARY BRAIN TUMOR PANEL (PBTP)

Christine Siegel, Orwa Aboud, Miranda Brown, Hye-Jung Chung, Mark Raffeld, Sonja Crandon, Ming Ji, Jason Levine, Elizabeth Vera, Snehal Patel, Jennifer Reyes, Terri Armstrong, Liqiang Xi, Alvina Acquaye, Lisa Boris, Nicole Briceno, Nancy Garren, Carlos Romo, Martha Quezado, Jing Wu, Brett Theeler and Mark Gilbert.

in Neuro-Oncology

November 2018; p ublished online November 2018 .

Journal Article. Subjects: Medical Oncology; Neurology. 0 words.

Abstract

BACKGROUND

The use of molecular diagnostics is an integral component of CNS cancer care. The NIH NOB PBTP...

Go to »  full text

P15.03CARER PERCEPTIONS OF THE END OF LIFE PHASE IN MALIGNANT GLIOMA IN SOUTH EAST SCOTLAND

S. McNamara, J.C. Day, S. Erridge, S. Peoples and R. Grant.

in Neuro-Oncology

September 2014; p ublished online September 2014 .

Journal Article. Subjects: Medical Oncology; Neurology. 0 words.

INTRODUCTION: Little is known about Health-Related Quality of Life of glioma patients during the end-of-life-phase of care. During this time, patients may experience a number of...

Go to »  full text   » abstract

BI-08MICROVESICLES CAN DISTINGUISH BETWEEN TUMOR PROGRESSION AND TREATMENT EFFECT/PSEUDOPROGRESSION IN GLIOBLASTOMA PATIENTS TREATED WITH RADIATION AND TEMOZOLOMIDE

Sydney M. Evans, Cameron J. Koch and Robert Lustig.

in Neuro-Oncology

November 2014; p ublished online November 2014 .

Journal Article. Subjects: Medical Oncology; Neurology. 0 words.

The standard of care for glioblastoma (GB) is radiation therapy (RT) and temozolomide (TMZ) following optimal surgery. This regimen has been accompanied by an increase in the occurrence of...

Go to »  full text   » abstract

Recursive partitioning analysis of prognostic variables in newly diagnosed anaplastic oligodendroglial tumors

Katherine S. Panageas, Anne S. Reiner, Fabio M. Iwamoto, Timothy F. Cloughesy, Kenneth D. Aldape, Andreana L. Rivera, April F. Eichler, David N. Louis, Nina A. Paleologos, Barbara J. Fisher, Lynn S. Ashby, J. Gregory Cairncross, Gloria B. Roldán Urgoiti, Patrick Y. Wen, Keith L. Ligon, David Schiff, H. Ian Robins, Brandon G. Rocque, Marc C. Chamberlain, Warren P. Mason, Susan A. Weaver, Richard M. Green, Francois G. Kamar, Lauren E. Abrey, Lisa M. DeAngelis, Suresh C. Jhanwar, Marc K. Rosenblum and Andrew B. Lassman.

in Neuro-Oncology

November 2014; p ublished online July 2014 .

Journal Article. Subjects: Medical Oncology; Neurology. 2884 words.

Background

Anaplastic oligodendroglial tumors are rare, and median survival varies widely. Analysis of 1p19q deletion is performed commonly and is an...

Go to »  full text   » abstract

O10.01PROGNOSTIC AND PREDICTIVE BIOMARKER-BASED SUBGROUPS IN THE NOA-04 TRIAL

W. Wick, D. Capper, M. Sill, V. Hovestadt, S.M. Pfister, M. Platten, G. Reifenberger, A. von Deimling, M. Weller and B. Wiestler.

in Neuro-Oncology

September 2014; p ublished online September 2014 .

Journal Article. Subjects: Medical Oncology; Neurology. 0 words.

BACKGROUND: Molecular biomarkers, including isocitrate dehydrogenase 1 or 2 (IDH1/2) mutation, 1p/19q codeletion, mutations and (consequently) loss of expression of alpha-thalassemia/mental...

Go to »  full text   » abstract

P16.35DELAYED CONTRAST MRI FOR DIFFERENTIATING TUMOR FROM TREATMENT EFFECTS IN CONVENTIONAL AND ANTI-ANGIOGENIC TREATMENTS

D. Daniels, D. Guez, D. Last, L. Zach, Y. Mardor and TRAMs author group.

in Neuro-Oncology

September 2014; p ublished online September 2014 .

Journal Article. Subjects: Medical Oncology; Neurology. 0 words.

Conventional MRI is unable to differentiate progression from treatment effects (TEs) in brain tumor (BT) patients. We have applied a novel technique, based on MR images acquired with a...

Go to »  full text   » abstract

O7.02RADIOSURGERY AND BRAIN METASTASES: ADEQUATE SEQUENCE OF BRAIN MRI CAN SIGNIFICANTLY CHANGE THE INTRACRANIAL DISEASE STAGING

S. Scoccianti, D. Greto, L. Bordi, P. Bono, G. Pecchioli, M. Casati, E. Vanzi, A. Compagnucci, D. Gadda and L. Livi.

in Neuro-Oncology

September 2014; p ublished online September 2014 .

Journal Article. Subjects: Medical Oncology; Neurology. 0 words.

INTRODUCTION: Accurate assessment of the exact number of brain metastases is of utmost importance in the decision-making process for the appropriate treatment. The diagnostic efficacy in...

Go to »  full text   » abstract

P06.15LONG TERM QUALITY OF LIFE OF ELDERLY PEOPLE IN DIFFERENT AGE GROUPS AFTER MENINGIOMA SURGERY

M. Timmer, M. Seibl-Leven, K. Wittenstein and R. Goldbrunner.

in Neuro-Oncology

September 2014; p ublished online September 2014 .

Journal Article. Subjects: Medical Oncology; Neurology. 0 words.

OBJECTIVE: Surgery is usually the standard treatment for intracranial meningiomas in patients of all ages. The incidence of meningiomas increases progressively with age. Considering the...

Go to »  full text   » abstract

P16.27DIFFERENTIATING BRAIN RADIONECROSIS FROM TUMOR RECURRENCE: A ROLE FOR CONTRAST ENHANCED ULTRASOUND (CEUS)? CASE REPORT

L. Mattei, F. Prada, F. Legnani, C. Casali, A. Filippini, A. Perin, M. Saini, A. Saladino, I. Vetrano and F. DiMeco.

in Neuro-Oncology

September 2014; p ublished online September 2014 .

Journal Article. Subjects: Medical Oncology; Neurology. 0 words.

BACKGROUND: Differentiating radionecrosis from local tumor recurrence is a major concern in the management of patients harbouring a cerebral tumor and treated with radiotherapy. In these...

Go to »  full text   » abstract

NI-19THE USE OF DYNAMIC O-(2-[18F]fluoroethyl)-L-TYROSINE-PET IN THE CLINICAL EVALUATION OF BRAIN TUMORS IN CHILDREN AND ADOLESCENTS

Veronika Dunkl, Corvin Cleff, Gabriele Stoffels, Nathalie Judov, Sevgi Sarikaya-Seiwert, Ian Law, Lars Bøgeskov, Karsten Nysom, Sofie B. Andersen, Hans-Jakob Steiger, Gereon R. Fink, Guido Reifenberger, Nadim J. Shah, Heinz H. Coenen, Karl-Josef Langen and Norbert Galldiks.

in Neuro-Oncology

November 2014; p ublished online November 2014 .

Journal Article. Subjects: Medical Oncology; Neurology. 0 words.

BACKGROUND: Experience regarding the use of dynamic O-(2-[18F]-fluoroethyl)-L-tyrosine (18F-FET) PET in children and adolescents with brain tumors is limited. METHODS: Sixty-nine 18F-FET...

Go to »  full text   » abstract

NI-65DIFFERENTIATING RADIATION EFFECT AND NECROSIS FROM GLIOBLASTOMA WITH DYNAMIC SUSCEPTIBILITY CONTRAST (DSC) MRI

Melissa Prah, Mona Al-Gizawiy, Wade Mueller, Raymond Hoffmann and Kathleen Schmainda.

in Neuro-Oncology

November 2014; p ublished online November 2014 .

Journal Article. Subjects: Medical Oncology; Neurology. 0 words.

BACKGROUND: In glioblastoma (GBM), pseudoprogression (PsP) appears as increased enhancement on T1-weighted imaging following concurrent chemoradiotherapy (CRT), making it difficult to...

Go to »  full text   » abstract

P04.25MOLECULAR ANALYSIS OF STEREOTACTIC BIOPSIES COMPARED TO TISSUE SAMPLES FROM OPEN TUMOR RESECTIONS IN GLIOMAS

M. Timmer, M. Perrech, G. Röhn, D. Rueß, T. Blau, N. Breuer, R. Goldbrunner and M. Ruge.

in Neuro-Oncology

September 2014; p ublished online September 2014 .

Journal Article. Subjects: Medical Oncology; Neurology. 0 words.

Biomarkers, genetic alterations and epigenetic marks gain in importance as prognostic and predictive markers both, after primary diagnosis and in the recurrent disease situation. However,...

Go to »  full text   » abstract

QLIF-46. THE EXPERIENCE OF MEDICAL CARE-RELATED DECISIONS AMONG MALIGNANT BRAIN TUMOR PATIENTS IN JAPAN: QUALITATIVE INTERVIEWS

Hanako Numata, Maiko Noguchi-Watanabe, Shota Tanaka, Shunsaku Takayanagi, Akitake Mukasa, Nobuhito Saito and Noriko Yamamoto-Mitani.

in Neuro-Oncology

November 2017; p ublished online November 2017 .

Journal Article. Subjects: Medical Oncology; Neurology. 0 words.

Abstract

AIMS

To elucidate the experiences of medical care-related decisions among patients with malignant brain...

Go to »  full text